N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide
C20H15F2N5O3 — CID 135955411
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide
N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide (PubChem CID 135955411) has the molecular formula C20H15F2N5O3 and a molecular weight of 411.37 g/mol. Its IUPAC name is N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide.
Molecular Properties
| Compound Name | N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide |
|---|---|
| PubChem CID | 135955411 |
| Molecular Formula | C20H15F2N5O3 |
| Molecular Weight | 411.37 g/mol |
| Exact Mass | 411.11 |
| IUPAC Name | N-[1-(4,5-dimethyl-6-oxo-1H-pyrimidin-2-yl)-3-(furan-2-yl)pyrazol-5-yl]-3,4-difluorobenzamide |
| SMILES | Cc1nc(-n2nc(-c3ccco3)cc2NC(=O)c2ccc(F)c(F)c2)[nH]c(=O)c1C |
| InChI | InChI=1S/C20H15F2N5O3/c1-10-11(2)23-20(25-18(10)28)27-17(9-15(26-27)16-4-3-7-30-16)24-19(29)12-5-6-13(21)14(22)8-12/h3-9H,1-2H3,(H,24,29)(H,23,25,28) |
| InChIKey | FHHHPINIDQTROV-UHFFFAOYSA-N |
| XLogP | 3.36 |
| TPSA | 105.81 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.37 |
| LogP ≤ 5 | 3.36 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135955411 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.